Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Post-ICU Telehealth Follow-up.
- Who it may be relevant to
- Registry conditions: Post Intensive Care Syndrome (PICS). Basic parameters: 18 years — 89 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial
Overview
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.
Interventions
- Behavioral Post-ICU Telehealth Follow-up
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Primary outcome measures
- Completion of Post-ICU follow-up [Time frame: From enrollment to end of follow-up period at seven months]
Secondary outcome measures (4)
- Quality of life at 6 months using the Short Form Survey (SF-36) [Time frame: From enrollment to 7 months]
- Hospital or ICU re-admissions [Time frame: Enrollment up to 7 months]
- Emergency department visits [Time frame: Enrollment up to 7 months]
- Mortality [Time frame: within 6 months post-hospital discharge]
Eligibility criteria
Inclusion criteria
- Adults 18-89 years of age
- Required admission to either medical or surgical ICU
- Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
- Anticipated discharge to home after hospitalization
- Consent from patients themselves or a legally authorized representative if necessary
Exclusion criteria
- Pregnancy
- Incarceration/Imprisonment
- Life expectancy less than 6 months or enrolled in hospice/palliative care
- Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
- Unable to participate in telehealth
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Malcom Randall Veterans Affairs Medical Center — Gainesville
Identifiers
NCT: NCT06983496 · IRB202401793